8LQ-22279-90847
2 vaccinations
1 coded response
19 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 805 / CO
- Registered
- 2021-02-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-19
Dose 1 — Pfizer-BioNTech
-
2021-02-25
Registered in v-safe
- 2021-02-25
- 2021-02-26
- 2021-03-05
-
2021-03-12
Dose 2 — Pfizer-BioNTech
- 2021-03-12
-
2021-03-13
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-14
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-15
- 2021-03-16
- 2021-03-17
- 2021-03-18
- 2021-03-19
- 2021-03-26
- 2021-04-04
- 2021-04-09
- 2021-04-16
- 2021-04-23
- 2021-06-11
- 2021-09-10
-
2022-03-12
Survey response — 12 months, dose 2MedDRA: Abortion spontaneous, Nasopharyngitis, Pregnancy — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Pregnancy, miscarriage, coldMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-19 | Pfizer-BioNTech | |
| 2 | 2021-03-12 | Pfizer-BioNTech |
Free text
Release 11 — 12 months, dose 2
Symptoms: Pregnancy, miscarriage, cold
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release